Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis

(2012) Edward J. Mills et al.   ANNALS OF MEDICINE

Evolution of Heterogeneity (I2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses

(2012) Kristian Thorlund et al.   PLoS One

An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes

(2011) Eleanor M. Pullenayegum   STATISTICS IN MEDICINE

Linear inference for mixed treatment comparison meta-analysis: A two-stage approach

(2011) Guobing Lu et al.   Research Synthesis Methods

Modeling between-trial variance structure in mixed treatment comparisons

(2009) G. Lu et al.   BIOSTATISTICS

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials

(2009) Tahany Awad et al.   HEPATOLOGY

The BUGS project: Evolution, critique and future directions

(2009) David Lunn et al.   STATISTICS IN MEDICINE

Undue reliance on I 2 in assessing heterogeneity may mislead

(2008) Gerta Rücker et al.   BMC Medical Research Methodology